public-health-2018-scientifictracks-abstracts

21 / 46

Page 69
Notes:
conferenceseries.com
Volume 8 J Community Med Health Educ, an open access journal
ISSN: 2161-0711 Public Health 2018
February 26-28, 2018
PUBLIC HEALTH AND NUTRITION
3rd World Congress on
February 26-28, 2018 London, UK
PREVENTION, INTERVENTION,ANDCONTROLOFAN INDIVIDUALS STATEOFHEALTH-
ME-BYO CONCEPT IN KANAGAWA PREFECTURE.
Madoka Takeuchia and Ikuko Tomomatsu b
aKanagawa Center for Clinical Research and Strategy, Japan
bEagle Matrix Consulting Co. Ltd, Japan
Kanagawa is one of the smallest prefectures in Japan and is located south of Tokyo. In contrast to the area, Kanagawa is the
2nd most populated prefecture with about 9 million citizens, simliar to the population of Switerzland and Austria. In the
1970s, the population of people 70 years and older comprised a small portion of the total population, however, it is expected
that in 2050, over 30% of the population will be over 70 years old, making Kanagawa a super-aging population. To address the
challenges of the increasing aging population, Governor Yuji Kuroiwa introduced the ME-BYO concept. ME-BYO evaluates
an individual`s state of health to effectively and efficiently prevent, treat and control disease, ultimately leading to prolonged
“healthy longevity.” No matter how sick or healthy an individual may be, the individual can always strive to be healthier. Along
with the ME-BYO concept, Kanagawa Prefecture has a mission to develop and integrate innovative healthcare technologies
driving changes toward a more efficient healthcare system. Advanced innovative medical technologies such as regenerative
medicine to cure diseases and Robotics/exoskeleton suits to aid and assist in care of the elderly are examples of strategies to
extend healthy life expectancy. In addition to research and development of innovative interventions, Kanagawa is focusing on
strengthening the educational program for medical and nonmedical healthcare professionals.
Biography
Madoka Takeuchi graduated from Columbia University, Mailman School of Public Health with a Master of Science in Biostatistics. Her specialties include clinical trial
design and methodology. After obtaining her Masters, she worked as a biostatistician with several university hospitals, academic institutions and pharmaceutical
companies. She is currently a lecturer at Keio Unversity a senior research fellow at Kanagawa Center for Clinical Research and Strategy and a consultant for
several ongoing research studies.
Madoka Takeuchi et al., J Community Med Health Educ 2018, Vol 8
DOI: 10.4172/2161-0711-C1-032